Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). (Q34214164)

31 July 2017

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). (English)

1 reference

31 July 2017

1 reference

Peter H Jones

1

1 reference

31 July 2017

Michael H Davidson

2

1 reference

31 July 2017

Evan A Stein

3

1 reference

31 July 2017

Harold E Bays

4

1 reference

31 July 2017

James M McKenney

5

1 reference

31 July 2017

Elinor Miller

6

1 reference

31 July 2017

Valerie A Cain

7

1 reference

31 July 2017

James W Blasetto

8

1 reference

31 July 2017

STELLAR Study Group

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

American Journal of Cardiology

31 July 2017

1 reference

31 July 2017

92

1 reference

31 July 2017

152-160

1 reference

31 July 2017

2

1 reference

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900530-7

Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900530-7

Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900530-7

Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: a randomized, double-blind study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900530-7

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900530-7

Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900530-7

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900530-7

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900530-7

Drug treatment of lipid disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900530-7

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900530-7

10.1016/S0002-9149(03)00530-7

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference